login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MEDICUS PHARMA LTD (MDCX) Stock News
NASDAQ:MDCX - Nasdaq -
CA58471K2020
-
Common Stock
- Currency: USD
2.21
+0.24 (+12.18%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MDCX Latest News, Press Relases and Analysis
All
Press Releases
2 months ago - By: Benzinga
- Mentions:
BLRX
CLGN
BWNB
BURU
...
Nasdaq Down 100 Points; Chicago PMI Dips In May
2 months ago - By: Benzinga
- Mentions:
ENTO
BSLK
REGN
BMGL
...
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
2 months ago - By: Quantum BioPharma
- Mentions:
QNTM
-
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari
5 months ago - By: Medicus Pharma Ltd
Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
6 months ago - By: Medicus Pharma Ltd
Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
6 months ago - By: Medicus Pharma Ltd
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
6 months ago - By: Medicus Pharma Ltd
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
8 months ago - By: Medicus Pharma Ltd
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
8 months ago - By: Medicus Pharma Ltd
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
9 months ago - By: Medicus Pharma Ltd
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
8 years ago - By: MDCorp
MDCorp Updates Training and Partnership with Smart Medical Systems
8 years ago - By: MDCorp
MDCorp Enters $450 Million European Endoscope Systems Sales Market
Please enable JavaScript to continue using this application.